Part,  Chapter, Paragraph

 1   II,     6.Acr    |       Human Papilloma Virus~IDU~Injecting Drug Users~LGV~Lymphogranuloma
 2   II,     6.  3.  3|    diagnosed cases of HIV among injecting drug users (IDU) accounts
 3   II,     6.  3.  3|      liver cirrhosis or cancer. Injecting drug use is the dominant
 4   II,     9.  3.  1|  Diabetes Federation Atlas~IDUs~Injecting drug users~LOH~Late Onset
 5  III,    10.  2.  1|       HCV~Hepatitis C Virus~IDU~Injecting Drug Users~NSP~Needle and
 6  III,    10.  2.  1|     snorting, swallowing and/or injecting. The last one is generally
 7  III,    10.  2.  1|       defined by the EMCDDA as ‘injecting drug use or long duration /
 8  III,    10.  2.  1|          estimates include only injecting drug users (IDUs) and problem
 9  III,    10.  2.  1|        Problem opioid users and injecting drug users still remain
10  III,    10.  2.  1|          Problem opioid use and injecting drug use~ ~Recent estimates
11  III,    10.  2.  1|     amphetamine/methamphetamine injecting problem.~ ~Time trends in
12  III,    10.  2.  1|      opioid, mainly heroin, and injecting drug use during the 80s
13  III,    10.  2.  1|      incidence of heroin use or injecting of diverted opioid medications
14  III,    10.  2.  1|      the transmission of HIV in injecting drug users (IDUs) continued
15  III,    10.  2.  1|         4. HIV prevalence among injecting drug usersstudies with
16  III,    10.  2.  1|        coverage, 2004-2005, all injecting drug users~ ~In recent years,
17  III,    10.  2.  1|    Hepatitis C infections among injecting drug users is very widespread
18  III,    10.  2.  1|       antibody prevalence among injecting drug users, 2004-2005, all
19  III,    10.  2.  1|      drug users, 2004-2005, all injecting drug users~ ~Among the other
20  III,    10.  2.  1|      increase of opiate use and injecting drug use in the eighties
21  III,    10.  2.  1|    health-risks related to drug injecting. The exchange or distribution
22  III,    10.  2.  1|       the level of provision of injecting material vary greatly between
23  III,    10.  2.  1|       for the access to sterile injecting equipment. Eight countries
24  III,    10.  2.  1|         cocaine overdoses among injecting and non-injecting cocaine
25  Key,   Ap5.  0.  0| influenza~influenzae~inhalation~injecting~injuries~injury~in-patient~